Judith Mitchell

Judith Mitchell, MD, FACC, FAHA serves as Assistant Professor of Medicine within the Cardiology division of the Department of Medicine at SUNY Downstate Medical Center's School of of Medicine. Her clinical expertise spans heart failure management and non-invasive cardiology with specialized board certifications in Cardiovascular Disease, Nuclear Cardiology, Adult Echocardiography, and Advanced Heart Failure/Transplant Cardiology.

Educational background includes:

• Medical Degree: Tufts University School of Medicine (1983-1987)
• Residency: Albert Einstein College of Medicine Hospitals (1987-1990)
• Cardiology Fellowship: Albert Einstein College of Medicine Hospitals (1990-1993)

Her research program critically examines heart failure disparities in African American populations, investigating intersections of atrial fibrillation, anemia, thyroid dysfunction, and gender-specific outcomes. As a principal investigator in the landmark African-American Heart Failure Trial (A-HeFT), she contributed to evidence-based treatment protocols that transformed care standards for underserved communities. Her scholarly work consistently bridges clinical practice with guideline development through active participation in American Heart Association initiatives.

Publication analysis reveals sustained focus on heart failure pathophysiology (78% of articles), health equity (45%), and non-invasive diagnostics (32%) between 2004-2013. Key trends include emphasis on racial disparities in treatment response, comorbidity management, and implementation of guideline-directed medical therapy in real-world settings.

Professional recognition includes:

• Extraordinary Women of Downstate Medical Center (2009)

Dr. Mitchell maintains active roles in guideline committees and scientific review panels, notably contributing to the 2013 ACCF/AHA Heart Failure Management Guidelines and serving as invited reviewer for valvular heart disease updates. Her clinical practice integrates advanced echocardiographic techniques with comprehensive heart failure management protocols. Current research continues to explore therapeutic optimization in heart failure with preserved ejection fraction and pharmacogenomic influences on treatment response within minority populations.